Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT)

Historical Holders from Q3 2019 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Symbol
HCAT on Nasdaq
Shares outstanding
70,886,873
Price per share
$2.38
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares as of 30 Sep 2025
54,134,701
Total reported value
$154,287,092
% of total 13F portfolios
0%
Share change
-128,018
Value change
-$4,603,372
Avg buy value change
+0%
Avg sell value change
-0%
Number of holders
141
Price from insider filings
$2.64
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
First Light Asset Management, LLC 20% -0.35% $41,210,964 -$137,918 13,922,623 -0.33% Mathew P. Arens 01 Dec 2025
BlackRock, Inc. 6.3% $17,542,785 4,407,735 BlackRock, Inc. 31 Mar 2025
VANGUARD GROUP INC 5.9% $16,443,979 4,131,653 The Vanguard Group 31 Mar 2025
Stoney Lonesome HF LP 5.5% $11,540,383 3,898,778 COGHILL CLINT D 15 Dec 2025
Whetstone Capital Advisors, LLC 5.4% $10,559,720 3,731,350 Whetstone Capital Advisors, LLC 30 Jun 2025
As of 30 Sep 2025, Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) has 141 institutional shareholders filing 13F forms. They hold 54,134,701 shares. of 70,886,873 outstanding shares (76%) .

Top 25 institutional shareholders own 69% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
First Light Asset Management, LLC 19% 13,436,220 +9.9% 3.6% $38,293,227
BlackRock, Inc. 7.8% 5,503,403 -2.6% 0% $15,684,699
VANGUARD GROUP INC 6.1% 4,295,691 +2.9% 0% $12,242,719
Whetstone Capital Advisors, LLC 5.3% 3,731,350 0% 2.9% $10,634,348
Impax Asset Management Group plc 3.9% 2,750,000 0% 0.05% $7,837,500
DIMENSIONAL FUND ADVISORS LP 2.7% 1,914,096 -3.5% 0% $5,455,559
GEODE CAPITAL MANAGEMENT, LLC 2.5% 1,738,904 +4.6% 0% $4,956,807
MILLENNIUM MANAGEMENT LLC 2.2% 1,589,536 +2513% 0% $4,530,178
Nepsis Inc. 2.1% 1,513,032 -12% 1.4% $4,312,141
PRIMECAP MANAGEMENT CO/CA/ 1.9% 1,369,067 -31% 0% $3,901,841
STATE STREET CORP 1.8% 1,273,754 +3.8% 0% $3,630,199
ACADIAN ASSET MANAGEMENT LLC 1.6% 1,125,804 -3.3% 0.01% $3,206,000
Palogic Value Management, L.P. 1.5% 1,091,819 +50% 1.3% $3,111,684
Connor, Clark & Lunn Investment Management Ltd. 1.4% 970,689 -9% 0.01% $2,766,464
KENNEDY CAPITAL MANAGEMENT LLC 1.4% 962,681 -10% 0.06% $2,743,641
JPMORGAN CHASE & CO 1.1% 810,767 -11% 0% $2,310,688
AMH Equity Ltd 0.93% 660,000 +55% 2.4% $1,881,000
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.88% 622,688 +4% 0% $1,774,661
Baird Financial Group, Inc. 0.87% 617,183 0% $1,758,972
GOLDMAN SACHS GROUP INC 0.79% 559,652 +35% 0% $1,595,008
NORTHERN TRUST CORP 0.75% 528,811 +0.35% 0% $1,507,113
MARTIN & CO INC /TN/ 0.72% 512,127 +0.58% 0.26% $1,459,561
MOORE CAPITAL MANAGEMENT, LP 0.56% 398,857 +131% 0.02% $1,136,742
Alyeska Investment Group, L.P. 0.49% 346,089 0% 0% $986,354
HighMark Wealth Management LLC 0.44% 310,282 +88% 0.39% $884,304

Institutional Holders of Health Catalyst, Inc. - Common Stock, par value $0.001 per share (HCAT) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2025 Q4 149,194 $354,906 -$5,980 238% 3
2025 Q3 54,134,701 $154,287,092 -$4,603,372 285% 141
2025 Q2 54,164,187 $204,239,601 +$2,031,442 377% 144
2025 Q1 53,179,756 $240,899,632 -$15,089,868 453% 163
2024 Q4 51,714,283 $365,529,299 +$10,713,924 707% 164
2024 Q3 52,033,442 $423,157,153 +$11,669,218 814% 158
2024 Q2 50,973,377 $325,694,724 +$3,633,936 639% 159
2024 Q1 50,065,423 $376,991,717 +$764,949 753% 170
2023 Q4 49,726,125 $460,463,313 +$1,604,271 926% 165
2023 Q3 49,374,836 $499,663,628 +$2,966,722 1,012% 155
2023 Q2 48,824,578 $610,231,678 +$4,102,989 1,250% 152
2023 Q1 48,547,295 $566,456,324 -$1,965,202 1,167% 158
2022 Q4 48,846,831 $519,237,991 -$2,727,981 1,063% 164
2022 Q3 49,010,406 $475,542,822 -$73,165,265 970% 163
2022 Q2 52,853,537 $766,547,805 -$46,880,972 1,449.01% 170
2022 Q1 53,285,286 $1,391,839,063 -$65,374,738 2,613.02% 180
2021 Q4 55,189,855 $2,186,203,412 +$48,206,866 3,962% 178
2021 Q3 53,304,379 $2,668,051,943 +$252,469,889 5,001.02% 198
2021 Q2 48,146,470 $2,673,141,898 +$252,885,500 5,551% 197
2021 Q1 43,869,916 $2,051,715,173 +$163,395,411 4,676.95% 187
2020 Q4 40,380,352 $1,757,762,073 +$87,929,967 4,353% 168
2020 Q3 40,018,208 $1,463,894,335 +$230,365,790 3,660% 138
2020 Q2 33,977,864 $991,115,334 +$212,900,758 2,916.99% 127
2020 Q1 27,081,811 $708,117,425 +$93,437,343 2,614.99% 107
2019 Q4 23,424,591 $810,679,210 +$30,418,007 3,470% 87
2019 Q3 16,697,494 $523,337,673 +$523,337,674 3,164% 85